GBA1 and Parkinson disease: Compared with the general population, patients with GD type 1 have a 20‐fold increased lifetime risk of developing parkinsonism [13], whereas individuals carrying heterozygous GBA1 mutations have a five times greater risk of developing PD than noncarrier individuals [8, 14, 15].